Interference with ubiquitination causes oxidative damage and increased protein nitration: Implications for neurodegenerative diseases

Journal of Neurochemistry

Volumn 90, Issue 2, 2004, Pages 422-430

  Hyun, Dong Hoon ^a   Gray, Douglas A ^b   Halliwell, Barry ^c   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

4 hydroxy 2,3 trans nonenal; Hydrogen peroxide; Oxidative damage; Proteasome; Serum withdrawal; Ubiquitin

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; CARBONYL DERIVATIVE; CELL PROTEIN; DNA; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; HYDROGEN PEROXIDE; NITRATE; NITRITE; PEROXYNITRITE; POLYUBIQUITIN; PROTEASOME; UBIQUITIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NITRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MODIFICATION; PROTEIN NITRATION; PROTEIN OXIDATION; SERUM; UBIQUITINATION;

ALDEHYDES; ANTIOXIDANTS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CLONE CELLS; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; GENES, DOMINANT; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MULTIENZYME COMPLEXES; MUTATION; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; NITRATES; NITRITES; OXIDANTS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RECOMBINANT FUSION PROTEINS; TERATOCARCINOMA; TRANSFECTION; UBIQUITINS;

EID: 3142661740     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02493.x     Document Type: Article

References (62)

1. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P. and Halliwell B. (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196-1203.
2. Angulo A., Suto C. and Ghazal P. (1995) Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69, 3831-3837.
3. Biedler J. L., Roffler-Tarlov S., Schner M. and Freeman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
4. Canu N., Barbato C., Ciotti M. T., Serafino A., Dus L. and Calissano P. (2000) Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20, 589-599.
5. Chirico S. (1994) High-performance liquid chromatography-based thiobarbituric acid tests. Meth. Enzymol. 233, 314-318.
6. Coux O., Tanaka K. and Goldberg A. L. (1996) Structure and functions of the 20S and 26S proteasomes. Ann. Rev. Biochem. 65, 801-847.
7. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P. and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
8. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
9. Friguet B. and Szweda L. I. (1997) Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405 21-25.
10. Gai W. P., Blessing W. W. and Blumbergs P. C. (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118, 1447-1459.
11. Giasson B. I. and Lee V. M. (2001) Parkin and the molecular pathways of Parkinson's disease. Neuron 31, 885-888.
12. Good P. F., Hsu A., Werner P., Perl D. P. and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
13. Greenacre S. A. and Ischiropoulos H. (2001) Biological tyrosine nitration: a pathological function of nitric oxide and reactive oxygen species. Free Rad. Res. 34, 541-581.
14. Grune T., Reinheckel T. and Davies K. J. (1997) Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534.
15. Guevara I., Iwanejko J., Dembińska-Kiec A., Pankiewicz J., Wanat A., Anna P., Gobła̧ek I., Bartus S., Malczewska-Malec M. and Szczudlik A. (1998) Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 274, 177-188.
16. Halliwell B. (1997) What nitrates tyrosine? FEBS Lett. 411, 157-160.
17. Halliwell B. (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716.
18. Halliwell B. (2002) Hypothesis: proteasomal dysfunction. A primary event in neurodegeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. NY Acad. Sci. 962, 182-194.
19. Halliwell B. (2003) Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett. 540, 3-6.
20. Halliwell B. and Gutteridge J. M. C. (1999) Free Radicals in Biology and Medicine, 3rd edn., pp. 246-350. Oxford University Press, Oxford, UK.
21. Halliwell B. and Jenner P. (1998) Impaired clearance of oxidised proteins in neurodegenerative diseases. Lancet 351, 1510.
22. Harlow E. and Lane D. (1988) Antibodies: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
23. Hershko A. and Ciechanover A. (1998) The ubiquitin system. Ann. Rev. Biochem. 67, 425-479.
24. Hissin P. J. and Hilf R. (1976) A flourometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214-226.
25. Hyun D.-H., Lee M., Hattori N., Kubo S., Mizuno Y., Halliwell B. and Jenner P. (2002a) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J. Biol. Chem. 277, 28572-28577.
26. Hyun D.-H., Lee M., Halliwell B. and Jenner P. (2002b) Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J. Neurochem. 83, 360-370.
27. Hyun D.-H., Lee M., Halliwell B. and Jenner P. (2003) Proteasomal inhibition induces the formation of aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86, 363-373.
28. Ince P. G., Shaw P. J., Slade J. Y., Jones C. and Hudgson P. (1996) Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. 92, 395-403.
29. Iqbal K. and Grundke-Iqbal I. (1991) Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol. Neurobiol. 5, 399-410.
30. Kaur H. and Halliwell B. (1996) Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem. J. 318, 21-23.
31. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
32. Kelner G. S., Lee M., Clark M. E., Maciejewski D., McGrath D., Rabizadeh S., Lyons T., Bredesen D., Jenner P. and Maki R. A. (2000) The copper transport protein Atox1 promotes neuronal survival. J. Biol. Chem. 275, 580-584.
33. Khan J., Brennand D. M., Bradley N., Gao B., Bruckdorfer R. and Jacobs M. (1998) 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 332, 807-808.
34. Lee M., Hyun D.-H., Jenner P. and Halliwell B. (2001a) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32-41.
35. Lee M., Hyun D.-H., Jenner P. and Halliwell B. (2001b) Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J. Neurochem. 76, 957-965.
36. Lee M., Hyun D.-H., Halliwell B. and Jenner P. (2001c) Effect of overexpression of wild-type and mutant Cu,Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2. J. Neurochem. 78, 209-220.
37. Lindsten K., De Vrij F. M., Verhoef L. G., Fischer D. F., Van Leeuwen F. W., Hol E. M., Masucci M. G. and Dantuma N. P. (2002) Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157, 417-427.
38. Lopez Salon M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
39. Lyras L., Evans P. J., Shaw P. J., Ince P. G. and Halliwell B. (1996) Oxidative damage and motor neuron disease: difficulties in the measurement of protein carbonyls in human brain tissue. Free Radic. Res. 24, 397-406.
40. Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
41. Mayer R. J., Lowe J., Landon M., McDermott H. and Laszlo L. (1991) The role of protein ubiquitination in neurodegenerative disease. Acta Biol. Hung. 42, 21-26.
42. McNaught K. S. and Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194.
43. McNaught K. S., Lee M., Hyun D.-H. and Jenner P. (2001a) Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease. Adv. Neurol. 86, 73-82.
44. McNaught K. S., Olanow C. W., Halliwell B., Isacson O. and Jenner P. (2001b) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589-594.
45. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K. and Ihara Y. (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160.
46. Okada K., Wangpoenftrakul C., Osawa T., Toyokuni S., Tanaka K. and Uchida K. (1999) 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 274, 23787-23793.
47. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E. and Mattson M. P. (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44, 819-824.
48. Pickart C. M. (1997) Targeting of substrates to the 26S proteasome. FASEB J. 11, 1055-1066.
49. Refsgaard H. H., Tsai L. and Stadtman E. R. (2000) Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc. Natl Acad. Sci. USA 97, 611-616.
50. Reznick A. Z. and Packer L. (1994) Oxidative damage to proteins, spectrophotometric methods for carbonyl assay. Meth. Enzymol. 223, 357-363.
51. Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S. and Selkoe D. J. (2001) Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269.
52. Smith R. G., Henry Y. K., Mattson M. P. and Appel S. H. (1998) Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 44, 696-699.
53. Souza J. M., Giasson B. I., Chen Q., Lee V. M. and Ischiropoulos H. (2000a) Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 18344-18349.
54. Souza J. M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., Obin M., Ara J., Horwitz J. and Ischiropoulos H. (2000b) Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys. 380, 360-366.
55. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L. and Masliah E. (1998) Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367-372.
56. Tamura T., Nagy I., Lupas A., Lottspeich F., Cejka Z., Schoofs G., Tanaka K., De Mot R. and Baumeister W. (1995) The first characterization of a eubacterial proteasome: the 20S complex of Rhodococcus. Curr. Biol. 5, 766-774.
57. Tsirigotis M., Zhang M., Chiu R. K., Wouters B. G. and Gray D. A. (2001) Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents. J. Biol. Chem. 276, 46073-46078.
58. Udvardy A. (1993) Purification and characterization of a multiprotein component of the Drosophila 26 S (1500 kDa) proteolytic complex. J. Biol. Chem. 268, 9055-9062.
59. Voges D., Zwickl P. and Baumeister W. (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Ann. Rev. Biochem. 68, 1015-1068.
60. Whiteman M. and Halliwell B. (1999) Loss of 3-nitrotyrosine on exposure to hypochlorous acid: implications for the use of 3-nitrotyrosine as a biomarker in vivo. Biochem. Biophys. Res. Com. 258, 168-172.
61. Yermilov V., Rubio J. and Ohshima H. (1995) Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 376, 207-210.
62. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. and Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc. Natl Acad. Sci. USA 93, 2696-2701.